BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 4476544)

  • 21. Hormone and enzyme assays in pregnancy. II. The human chorionic somatomammotrophin, progesterone and placental cystine-aminopeptidase levels in normal pregnancy.
    Christensen A; Froyshov D; Fylling P
    Acta Endocrinol (Copenh); 1974 May; 76(1):201-8. PubMed ID: 4406585
    [No Abstract]   [Full Text] [Related]  

  • 22. [Establishment of prognosis in threatened abortion. Value of the combined use of diagnostic ultrasound and quantitative determination of chorionic gonadotropin hormone].
    Levi S; Hechtermans R; L'Hermite-Baleriaux M
    J Gynecol Obstet Biol Reprod (Paris); 1973 Mar; 2(2):155-60. PubMed ID: 4807235
    [No Abstract]   [Full Text] [Related]  

  • 23. HCG, HPL, oestradiol, progesterone and AFP in serum in patients with threatened abortion.
    Kunz J; Keller PJ
    Br J Obstet Gynaecol; 1976 Aug; 83(8):640-4. PubMed ID: 60125
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pattern of chorionic gonadotropins and placental lactogens during treatment of threatened and habitual abortion].
    Samochowiec E; Rzempołuch J; Bakaj J; Bielecka M
    Ginekol Pol; 1976 Dec; 47(12):1363-70. PubMed ID: 1010383
    [No Abstract]   [Full Text] [Related]  

  • 25. [Diagnostic examination methods in threatened pregnancy. Panel discussion].
    Arch Gynakol; 1975 Nov; 219(1-4):389-94. PubMed ID: 1243390
    [No Abstract]   [Full Text] [Related]  

  • 26. Bioactive to immunoreactive ratio of circulating human chorionic gonadotropin as possible evaluation for the prognosis of threatened abortion.
    Camejo MI; Proverbio F; Febres F; Casart YC
    Eur J Obstet Gynecol Reprod Biol; 2003 Aug; 109(2):181-4. PubMed ID: 12860338
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proceedings: Endocrine assessment of threatened abortion.
    Rewell RE
    J Clin Pathol; 1975 Sep; 28(9):757. PubMed ID: 1165313
    [No Abstract]   [Full Text] [Related]  

  • 28. [Diagnosis of placental insufficiency by radioimmunoassay of serum HCG and HPL].
    Spona J; Janisch H
    Wien Klin Wochenschr; 1972 Jun; 84(24):385-9. PubMed ID: 5042228
    [No Abstract]   [Full Text] [Related]  

  • 29. New thoughts in exploring the pathogenesis, diagnosis, and treatment of threatened abortion.
    Zhou J; Huang Z; Pan X; Leung WT; Li C; Chen L; Zhang Y; Wang L; Sima Y; Zhang N; Qiu X; Li L; Wang L
    Biosci Trends; 2019; 13(3):284-285. PubMed ID: 31327799
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of threatened and habitual abortion with human chorionic gonadotrophin. The role of serum human placental lactogen determination.
    Vorster CZ; Pannall PR; Slabber CF
    S Afr Med J; 1977 Feb; 51(6):165-6. PubMed ID: 841444
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Parallel study of serum LAP (leucine aminopeptidase) and HCG and PLH in normal and pathological pregnancy].
    Albertazzi E; Bartolotti A; Mantovani G; Turci M
    Minerva Ginecol; 1978 Mar; 30(3):201-5. PubMed ID: 662198
    [No Abstract]   [Full Text] [Related]  

  • 32. [Determination of chorionic gonadotropins and placental lactogen in monitoring of early pregnancy in women with pregestational ovarian insufficiency].
    Adamcio-Deptulska M; Gromadzki W; Jaworska-Karwowska J; Giedroyć B; Wojciechowska D; Wójcikowski C
    Ginekol Pol; 1980 May; 51(5):411-23. PubMed ID: 7409587
    [No Abstract]   [Full Text] [Related]  

  • 33. [Diagnosis and surveillance of early pregnancy complications with the determination of plasma estrone, estradiol-17 beta, estriol, progesterone and HPL and with the graduated urinary pregnancy test (proceedings)].
    Strecker JR; Negulescu R; Dahlén H; Musch K
    Arch Gynakol; 1977 Jul; 224(1-4):88-9. PubMed ID: 579954
    [No Abstract]   [Full Text] [Related]  

  • 34. [Prognosis and treatment of threatened abortion. C. Profile of hCG and steroids in 1st trimester spontaneous abortions].
    Scholler R; Chartier M; Barrat J; Roger M; Castanier M; Avigdor R
    J Gynecol Obstet Biol Reprod (Paris); 1980; 9(1):79-89. PubMed ID: 7451886
    [No Abstract]   [Full Text] [Related]  

  • 35. [Prognosis and treatment of threatened abortion. E. Management of the danger of abortion].
    Leng JJ
    J Gynecol Obstet Biol Reprod (Paris); 1980; 9(1):90-4. PubMed ID: 7451888
    [No Abstract]   [Full Text] [Related]  

  • 36. The use of human chorionic gonadotropin in recurrent abortion.
    Sandler SW; Baillie P
    S Afr Med J; 1979 May; 55(21):832-5. PubMed ID: 472911
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma hormone profile of threatened abortion and its prognosis.
    Miyakawa I; Ikeda I; Maeyama M
    Int J Gynaecol Obstet; 1977; 15(1):12-6. PubMed ID: 562785
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The hormonology of pregnancy].
    Lambotte R
    Rev Med Liege; 1980 Sep; 35(17):575-7. PubMed ID: 7455434
    [No Abstract]   [Full Text] [Related]  

  • 39. [Monitoring of high-risk pregnancies (author's transl)].
    Davi D; Vernotico V; Bottoni A; Vallini A; Candi L; Zanella B
    Quad Sclavo Diagn; 1978 Dec; 14(4):468-85. PubMed ID: 757621
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Practical screening for the dysfunctional feto-placental unit during pregnancy (author's transl)].
    Honda T
    Nihon Naibunpi Gakkai Zasshi; 1978 Oct; 54(10):1125-50. PubMed ID: 720693
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.